(Q41818161)

12 October 2017

Bone mass is related to creatinine clearance in normal elderly women (English)

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Orthopedics and sports medicine

28 November 2022

main subject

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

28 November 2022

author name string

E. R. Yendt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1796752

28 November 2022

M. Cohanim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1796752

28 November 2022

S. Jarzylo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1796752

28 November 2022

G. Jones

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1796752

28 November 2022

G. Rosenberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1796752

28 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1796752

28 November 2022

publication date

1 October 1991

1 reference

full work available at URL

12 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjbmr.5650061005

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

https://onlinelibrary.wiley.com/doi/full/10.1002/jbmr.5650061005

28 November 2022

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Journal of Bone and Mineral Research

28 November 2022

published in

1 reference

12 October 2017

6

1 reference

12 October 2017

10

1 reference

12 October 2017

1043-1050

1 reference

Osteoporosis in Women 45 Years and over Related to Subsequent Fractures

12 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650061005

Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650061005

The loss of bone mineral with aging and its relationship to risk of fracture

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

The ultrafiltrable calcium of human serum. I. Ultrafiltration methods and normal values

28 November 2022

7

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

A specific method for the analysis of hydroxyproline in tissues and urine

28 November 2022

10

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies

28 November 2022

12

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Estimation of Biologically Active Intact Parathyroid Hormone in Normal and Hyperparathyroid Sera by Sequential N-terminal Immunoextraction and Midregion Radioimmunoassay

28 November 2022

13

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate

28 November 2022

18

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives

28 November 2022

19

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Clinical and laboratory approaches for evaluation of nephrolithiasis

28 November 2022

20

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

28 November 2022

21

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

28 November 2022

22

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Long-term calcitonin therapy in postmenopausal osteoporosis

28 November 2022

23

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis

28 November 2022

24

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of action

28 November 2022

25

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Skeletal disease in primary hyperparathyroidism

28 November 2022

27

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass

28 November 2022

29

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

Differential effects of endocrine dysfunction on the axial and the appendicular skeleton

28 November 2022

30

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

28 November 2022

31

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061005

28 November 2022

Identifiers

1 reference

12 October 2017

1 reference